pegvisomant
Showing 1 - 22 of 22
Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)
Terminated
- Acromegaly
- Pegvisomant
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 12, 2022
Bone MicroArchitecture in Acromegaly
Completed
- Acromegaly
- Osteoporosis Risk
- Pegvisomant
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University
Jul 12, 2021
Acromegaly Trial in Canada (Pegvisomant)
Completed
- Acromegaly
- Pegvisomant
-
Edmonton, Alberta, Canada
- +4 more
Nov 19, 2021
Acromegaly Trial in Worldwide (lanreotide (Autogel formulation), Pegvisomant)
Completed
- Acromegaly
- lanreotide (Autogel formulation)
- Pegvisomant
-
Hradec Kralove, Czechia
- +23 more
Jan 4, 2019
Obesity Trial in Nashville (Sitagliptin, Pegvisomant, Placebo)
Completed
- Obesity
- Sitagliptin
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
May 25, 2018
Acromegaly Trial in Los Angeles (Pegvisomant)
Completed
- Acromegaly
- Pegvisomant
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 23, 2017
Diabetes, Metabolic Syndrome, Insulin Resistance Trial in San Francisco (pegvisomant)
Completed
- Diabetes
- +2 more
- pegvisomant
-
San Francisco, CaliforniaSan Francisco General Hospital
Apr 20, 2017
Healthy Trial in Aarhus (Fasting, Saline, Pegvisomant)
Completed
- Healthy
- Fasting
- +2 more
-
Aarhus, DenmarkAarhus University Hospital
Nov 22, 2016
Colorectal Tumors, Lung Tumors, Breast Tumors Trial in Worldwide (figitumumab, pegvisomant)
Terminated
- Colorectal Neoplasms
- +4 more
- figitumumab
- pegvisomant
-
Minneapolis, Minnesota
- +4 more
Oct 23, 2013
Adults Growth Hormone Deficiency. Trial in Portland (Pegvisomant, Regular insulin)
Unknown status
- Adults Growth Hormone Deficiency.
- Pegvisomant
- Regular insulin
-
Portland, OregonOregon Health & Science University
Oct 23, 2013
Bioavailability Trial in Singapore (pegvisomant)
Completed
- Bioavailability
- pegvisomant
-
Singapore, SingaporePfizer Investigational Site
Jan 4, 2012
Acromegaly, Insulin Resistance, Impaired Glucose Tolerance Trial in Aarhus C (Pegvisomant, Somatostatin analog (lanreotide or
Completed
- Acromegaly
- +2 more
- Pegvisomant
- Somatostatin analog (lanreotide or octreotide)
-
Aarhus C, Aarhus, DenmarkDepartment of Endocrinology, Aarhus University Hospital
Jan 25, 2012
Acromegaly, Heart Failure, Hypertrophy, Left Ventricular Trial in Wuerzburg (pegvisomant)
Unknown status
- Acromegaly
- +2 more
- pegvisomant
-
Wuerzburg, Bavaria, GermanyUniversity of Wuerzburg, Department of Endocrinology
Sep 23, 2010
Interaction Between the GH/IGF-I System and the Immune-system Trial in Herlev (Somatropin, Pegvisomant)
Unknown status
- Interaction Between the GH/IGF-I System and the Immune-system
- Somatropin
- Pegvisomant
-
Herlev, DenmarkDepartment of Endocrinology J 106, Herlev Hospital
Aug 31, 2009
Acromegaly Trial in Japan (Pegvisomant)
Completed
- Acromegaly
- Pegvisomant
-
Kobe City, Hyogo Pref, Japan
- +7 more
Jul 24, 2008
Acromegaly Trial in Munich (pegvisomant, combination with somatostatin analogue octreotide, combination with dopamine agonist
Completed
- Acromegaly
- pegvisomant
- +2 more
-
Munich, GermanyMedizinische Klinik - Innenstadt of the University of Munich
Mar 31, 2008
Quality of Life, Acromegaly Trial (Pegvisomant)
Completed
- Quality of Life
- Acromegaly
- Pegvisomant
- (no location specified)
Mar 24, 2008
Acromegaly Trial in Worldwide (Pegvisomant/ Sandostatin LAR, Sandostatin LAR, Pegvisomant)
Completed
- Acromegaly
- Pegvisomant/ Sandostatin LAR
- +2 more
-
Los Angeles, California
- +32 more
Apr 3, 2008
McCune Albright Syndrome, Polyostotic Fibrous Dysplasia Trial run by the NIDCR (Pegvisomant)
Completed
- McCune Albright Syndrome
- Polyostotic Fibrous Dysplasia
- Pegvisomant
-
Bethesda, MarylandNational Institute of Dental And Craniofacial Research (NIDCR)
Mar 3, 2008
Acromegaly Trial in Worldwide (Pegvisomant, Sandostatin LAR)
Completed
- Acromegaly
- Pegvisomant
- Sandostatin LAR
-
Los Angeles, California
- +54 more
Apr 3, 2008
Intracellular Signaling Peptides and Proteins Trial in Aarhus (Saline infusion, Human Growth Hormone, Pegvisomant)
Completed
- Intracellular Signaling Peptides and Proteins
- Saline infusion
- +2 more
-
Aarhus, DenmarkMedical Research Laboratories
Aug 6, 2007